Professor Fatima Merchant leads a team developing patient-specific molds for breast cancer patients, funded by a $2.7 million NIH grant. The project aims to improve reconstruction efficiency and psychosocial adjustment, featuring a randomized controlled clinical trial to evaluate impact.